Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

ItemNotesAcknowledgements of understanding of current design approach or public design approach discussion plans (attendee names)
Lab vocabulary discrepancy
  • Update: Lab Result Specimen Condition Acceptability and Lab Result Interpretation vocabulary discrepency issue:
    • USCDI Comment or errata will be forthcoming. Did not discuss details of what this will look like or when. But we should feel comfortable about proceeding with current HL7 vocabulary.

 

Medication Adherance

Medication Adherance

 -

In US Core this is an extension

with

(Medication Adherence

Observable Entity Code 418633004 at code and

) with SNOMED finding codes at value, correspondingly in C-CDA will be a Medication Adherence Observation Observable Entity Code 418633004 at code with an Observation with the SNOMED "answer" value set at observation.value. 

    • Discussion about FHIR-42845:
      • Carmela or Al will make a comment asserting that within the USCDI data elements' defintions ONC does not limit the exchange to any specific patient population (e.g. inpatient vs outpatient)

Carmela Minicucci Couderc and Albert W. Taylor agreed that MedicationRequest with the MedicationAdherance extension is the design going forward to ballot (https://build.fhir.org/ig/HL7/US-Core/StructureDefinition-us-core-medication-adherence.html)

In C-CDA it will be corresponding deisgn as an observation which is referenced from in medication Activity using same vocabulary (Medication Adherence Observation)

USCDI and Must Support in US Core

Brett reviewed proposal new format, to clarify whats must support vs USCDI flag. We discussed what "Additional USCDI" means as opposed to (USCDI)

Lots of discussion ensued about what is clear. Carmela would like this team to undertsand the new "Additional USCDI flagging" vs "Must support" and what is applied when. We should review next time when Eric's changes are imported into the formal build.


...